TATVA CHIN PHARM CHEM LTD
TATVA · General/Diversified · NSE
₹1,252
Current Market Price
Under Review— We don’t have enough data to publish a fair value estimate for TATVA yet. Reason: Data Limited.
Updated just now
YieldIQ Score
—
Piotroski F-Score
6/9
Economic Moat
None
Confidence
29%
ROE
0.8%
Debt/Equity
0.05
WACC
11.1%
Market Cap
₹2,930 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
4.7%
Return on capital employed
EV / EBITDA
29.9×
Enterprise multiple
Debt / EBITDA
1.2×
Leverage vs earnings
Interest Coverage
9.4×
EBIT covers interest
Current Ratio
2.76×
Short-term liquidity
Asset Turnover
0.60×
Revenue per ₹ of assets
Revenue CAGR (3Y)
6.3%
3-year revenue growth
Revenue CAGR (5Y)
8.6%
5-year revenue growth
Ratio Trends
TATVA · last 4 annual periods
ROE
0.8%
ROCE
4.7%
Operating Margin
—
Debt / Equity
0.05×
PE
230.3×
EV / EBITDA
64.9×
Historical Financials
TATVA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹431 Cr | ₹421 Cr | ₹390 Cr | ₹383 Cr | ₹506 Cr | +4.1% |
| EBITDA | ₹117 Cr | ₹62.3 Cr | ₹75.3 Cr | ₹36.5 Cr | ₹96.7 Cr | -4.6% |
| EBIT | ₹109 Cr | ₹53.2 Cr | ₹50.1 Cr | — | — | -17.7% |
| PAT | ₹95.9 Cr | ₹45.5 Cr | ₹30.4 Cr | ₹5.7 Cr | ₹42.1 Cr | -18.6% |
| EPS (diluted) | ₹44.59 | ₹20.52 | ₹13.26 | — | — | -26.2% |
| CFO | ₹20.2 Cr | ₹27.8 Cr | ₹98.0 Cr | ₹24.8 Cr | ₹31.5 Cr | +11.7% |
| CapEx | ₹-89.2 Cr | ₹-203 Cr | ₹-129 Cr | ₹-76.3 Cr | ₹-114 Cr | — |
| FCF | ₹-68.9 Cr | ₹-175 Cr | ₹-30.5 Cr | ₹-51.5 Cr | ₹-82.3 Cr | — |
| Total Assets | ₹658 Cr | ₹759 Cr | ₹819 Cr | ₹836 Cr | ₹1004 Cr | +11.1% |
| Total Debt | ₹120 Cr | ₹170 Cr | ₹14.3 Cr | ₹36.4 Cr | ₹120 Cr | +0.1% |
| Shareholders' Equity | ₹473 Cr | ₹515 Cr | ₹737 Cr | ₹739 Cr | ₹782 Cr | +13.4% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
TATVA vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 NOCIL NOCIL | — | — | Pending | 3.1% | — |
JUBLCPL JUBLCPL | — | — | Pending | 27.8% | — |
 ROSSARI ROSSARI | — | — | Pending | 11.5% | — |
 POLYPLEX POLYPLEX CORPORATION LTD | +25.5%+34.3% upside | 50 | Below Fair Value | 3.4% | — |
KIRIINDUS KIRIINDUS | — | — | Pending | 86.5% | 0.4× |
Click a ticker to view its fair-value analysis.
Dividend History
4 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹7.00/sh
Last payout
2025-09-12
₹1.00
Peak payout
₹2.00
Trailing yield
0.08%
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
Risk Analysis
Volatility & drawdown
Risk profile of TATVA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for TATVA →
Compare
Head-to-head with peers
Compare TATVA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse TATVANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.